Thursday, November 6, 2025

FSD Pharma Ends Class Action Lawsuit With $5.5 Million Settlement

FSD Pharma (CSE: HUGE) (NASDAQ: HUGE) this morning announced that it has settled a class action lawsuit that was filed against the firm in 2019. The class action itself was related to the build-out of its facility in Cobourg, Ontario, which in February 2019 took a turn for the worse when things fell apart with construction partner Auxly Cannabis (TSXV: XLY).

FSD this morning indicated that it has entered into a settlement agreement due to the desire to avoid the expense of court associated with forging ahead to fight the lawsuit. The company admitted no fault or liability in connection with the settlement.

Under the terms of the arrangement, the company will pay $5.5 million to settle the lawsuit, of which $4.6 million will be covered by insurance the company currently has in place. The remainder, $900,000, needs to be covered by the company directly.

To provide further clarity to our readers, this class action was filed February 22, 2019, by a shareholder of FSD whom filed a statement of claim in the Ontario Superior Court. Among other items, the claim alleged that FSD Pharma had made statements containing misrepresentations related to the build-out of the Cobourg facility.

The lawsuit was not filed by Auxly, as certain message boards seem to have misinterpretated. Rather, within regulatory filings, FSD Pharma explicitly states that “to date, neither party has taken further legal action against the counter party,” when referencing the events that transpired with Auxly.

FSD Pharma last traded at $2.14 on the CSE.


Information for this briefing was found via Sedar, and FSD Pharma. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

10 Responses

    1. I too lost over 50k and when I finally found out amd wanted to join the suit, they claimed I was a few months late to join . I don’t think that’s fair and that very shareholder should have been contacted.

  1. Have entered my name and number twice and called in regards to this class action lawsuit. Was always told I would be updated.

    I have lost over 10k from this company.

    416 389 0291

    Stef

  2. go to fsdsecuritiesclassaction.com all the info is there. Good Luck! would be nice to get some of our “stolen” money back.

    1. hi,
      I have lost almost $24000, since we are in the same boat and if you find any solution, kindly let me know which I will appreciate highly.
      best regards,
      kabita
      416 6253481

Video Articles

PMET Resources: Lithium Feasibility Study Sees Economics Tumble

Gold Is Not Rising. Confidence Is Collapsing | Todd “Bubba” Horwitz

IAMGOLD: The Quebec Buying Spree

Recommended

Antimony Resources Sees Bald Hill Potential Double In Latest Technical Report

Altamira Gold Adds Second Drill Rig To Ongoing Exploration Program Targeting Gold Porphyry’s

Related News

Auxly Cannabis Sees 2021 Revenue Growth Of 79%, Still EBITDA Negative

Auxly Cannabis (TSX: XLY) was amongst the numerous names that reported their fourth quarter and...

Thursday, March 31, 2022, 10:02:31 AM

Cannara Biotech & Its Ties to FSD Pharma

Cannara Biotech (CSE:LOVE) is set to start trading today under the ticker symbol LOVE on...

Monday, January 14, 2019, 02:00:30 PM

Auxly Signs Manufacturing And Distribution Deal With Dosist

Auxly Cannabis (TSXV: XLY) this morning announced that its PEI-based subsidiary Dosecann has entered into...

Wednesday, June 24, 2020, 08:44:35 AM

Auxly Cannabis Sees Imperial Brands Convert $123 Million In Debt To Equity Interest

Auxly Cannabis (TSX: XLY) has substantially bolstered its balance sheet, indicating this morning that Imperial...

Monday, April 1, 2024, 08:37:41 AM

Imperial Brands Tops Up Auxly Ownership

Imperial Brands has topped up its position in Auxly Cannabis (TSXV: XLY). The move is...

Tuesday, December 17, 2019, 08:14:58 AM